Grown Rogue International Inc. GRUSF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

56/100

2/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Grown Rogue International Inc. (GRUSF) trades at a trailing P/E of 12.6. Trailing earnings yield is 7.95%.

Criteria proven by this page:

VALUE (85/100, Pass) — P/E is below market average (12.6); earnings yield beats bond yields (7.95%).
Trailing Earnings Yield 7.95% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 55/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

56/100

SG Score

View full scorecard →

✓

VALUE

85/100

Price-to-Earnings & upside

Proven by this page

—

FUTURE

N/A

No coverage

PAST

50/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

28/100

→ Income

GROWTH

40/100

→ Income

✓

INCOME

85/100

→ Income

Valuation Snapshot — GRUSF

Valuation Multiples

P/E (TTM)12.6

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio3.72

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.03

Book Value / Share$0.00

Revenue / Share$0.09

FCF / Share$0.00

Yields & Fair Value

Earnings Yield7.95%

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-6.97	$0.00	$-10.34M	-
2017	$-0.01	$156.07K	$-302.4K	-193.8%
2018	$-0.23	$1.93M	$-7.58M	-392.1%
2019	$-0.14	$3.92M	$-9.72M	-247.5%
2020	$-0.03	$4.24M	$-3.15M	-74.4%
2021	$-0.01	$9.38M	$-1.01M	-10.8%
2022	$0.00	$17.76M	$447.46K	2.5%
2023	$0.00	$21.83M	$-518.01K	-2.4%
2024	$-0.05	$27.02M	$-11.3M	-41.8%
2025	$0.03	$22.15M	$6.36M	28.7%